/content/mofsl-website-adobe/fragments/open-demat-popup
style
hide-in-desktop

Cardio Diagnostics Holdings Inc Share Price Today: Live Updates & Key Insights

Cardio Diagnostics Holdings Inc share price today is $1.5, up -4.9%. The stock opened at $1.645 against the previous close of $1.6299, with an intraday high of $1.645 and low of $1.54.

Cardio Diagnostics Holdings Inc Share Price Chart

style
pb-0

Cardio Diagnostics Holdings Inc

us-stock
To Invest in {{usstockname}}
/content/mofsl-website-adobe/demat-form-fields
style
sticky-block,pt-0
us-stock
style
pt-0

Cardio Diagnostics Holdings Inc Share Price Performance

$1.5 -0.049(-4.9%) CDIO at 27 Jul 2026 02:23 PM Biotechnology
Lowest Today 1.54
Highest Today 1.645
Today’s Open 1.645
Prev. Close 1.6299
52 Week High 7.91
52 Week Low 0.97
Day’s Range: Low 1.54 High 1.645
52-Week Range: Low 0.97 High 7.91
1 day return -
1 Week return -3.01
1 month return -19.09
3 month return -12.02
6 month return -11.53
1 year return -61.75
3 year return +41.22
5 year return -
10 year return -

Cardio Diagnostics Holdings Inc Institutional Holdings

Jane Street Group LLC 2.75

HRT FINANCIAL LLC 2.11

BlackRock Inc 1.17

Geode Capital Management, LLC 1.09

Vanguard Group Inc 0.82

Vanguard Capital Management, LLC 0.68

Vanguard Institutional Extnd Mkt Idx Tr 0.68

Fidelity Extended Market Index 0.58

Renaissance Technologies Corp 0.52

Scientech Research LLC 0.47

UBS Group AG 0.34

Spartan Extended Market Index Pool F 0.15

Vanguard Fiduciary Trust Co 0.13

Fidelity Series Total Market Index 0.10

NT Ext Equity Mkt Index Fund - NL 0.08

Fidelity Total Market Index 0.08

Tower Research Capital LLC 0.07

NT Ext Equity Mkt Idx Fd - DC - NL - T2 0.06

Northern Trust Extended Eq Market Idx 0.04

NT Ext Equity Mkt Index Fund - Lending 0.04

Spartan Total Market Index Pool G 0.03

Extended Equity Market Fund B 0.03

Extended Equity Market Fund E 0.03

NT Ext Eq Mkt Idx Fd DC Lending Tier 5 0.02

Fidelity Nasdaq Composite Index 0.01

Wolverine Asset Management LLC 0.00

Morgan Stanley - Brokerage Accounts 0.00

Northern Trust Wilshire 5000 0.00

NT US Market Cap Index Fund - Ld 0.00

Advisor Group Holdings, Inc. 0.00

SHP Wealth Management 0.00

SBI Securities Co Ltd 0.00

Citadel Advisors Llc 0.00

Citigroup Inc 0.00

DRW Securities, LLC 0.00

SRS Capital Advisors Inc 0.00

Cardio Diagnostics Holdings Inc Market Status

Strong Buy: 1

Buy: 0

Hold: 0

Sell: 0

Strong Sell: 0

Cardio Diagnostics Holdings Inc Fundamentals

Market Cap 4.82 M

PB Ratio 0.5584

PE Ratio 0.0

Enterprise Value -1.57 M

Total Assets 7.77 M

Volume 1237965

Cardio Diagnostics Holdings Inc Company Financials

Annual Revenue FY23:12705 0.0M, FY22:950 0.0M, FY21:901 0.0M, FY20:0 0.0M

Annual Profit FY23:null 0.0M, FY22:950 0.0M, FY21:901 0.0M, FY20:null 0.0M

Annual Net worth FY23:-9365962 -9.4M, FY22:-4660985 -4.7M, FY21:-620448 -0.6M, FY20:-605164 -0.6M

Quarterly Revenue Q1/2026:2680 0.0M, Q3/2025:2855 0.0M, Q2/2025:7475 0.0M, Q1/2025:940 0.0M, Q3/2024:6580 0.0M

Quarterly Profit Q1/2026:-91972 -0.1M, Q3/2025:-86733 -0.1M, Q2/2025:-81668 -0.1M, Q1/2025:940 0.0M, Q3/2024:6580 0.0M

Quarterly Net worth Q1/2026:-1788158 -1.8M, Q3/2025:-1714536 -1.7M, Q2/2025:-1683199 -1.7M, Q1/2025:-1635064 -1.6M, Q3/2024:-1412566 -1.4M

About Cardio Diagnostics Holdings Inc & investment objective

Company Information Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. The company offers Epi+Gen CHD, a three-year symptomatic coronary heart disease (CHD) risk assessment clinical blood test targeting CHD events, including heart attacks; PrecisionCHD, an integrated epigenetic-genetic clinical blood test for the detection of coronary heart disease; and Actionable Clinical Intelligence, a platform that offers new epigenetic and genetic insights to clinicians prescribing to help improve chronic care management. It also provides CardioInnovate360, a research-use-only solution to support the discovery, development and validation of novel biopharmaceuticals for the assessment and management of cardiovascular diseases; and HeartRisk, a SaaS cardiovascular disease risk intelligence platform. It serves telemedicine providers; provider organizations, such as concierge practices, longevity clinics, and risk-bearing provider organizations; and employer organizations. Cardio Diagnostics Holdings, Inc. was founded in 2017 and is headquartered in Chicago, Illinois.

Organisation Biotechnology

Employees 15

Industry Biotechnology

CEO Dr. Meeshanthini V. Dogan Ph.D.

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right
style
align-center,button-arrow

Cardio Diagnostics Holdings Inc FAQs

What is the share price of Cardio Diagnostics Holdings Inc today?

The current share price of Cardio Diagnostics Holdings Inc is $1.5.

Can I buy Cardio Diagnostics Holdings Inc shares in India?

Yes, Indian investors can buy Cardio Diagnostics Holdings Inc shares by opening an international trading and demat account with Motilal Oswal.

How to buy Cardio Diagnostics Holdings Inc shares in India?

You can easily invest in Cardio Diagnostics Holdings Inc shares from India by:

Can I buy fractional shares of Cardio Diagnostics Holdings Inc?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of Cardio Diagnostics Holdings Inc?

Cardio Diagnostics Holdings Inc has a market cap of $4.82 M.

In which sector does Cardio Diagnostics Holdings Inc belong?

Cardio Diagnostics Holdings Inc operates in the Biotechnology sector.

What documents are required to invest in Cardio Diagnostics Holdings Inc stocks?

To invest, you typically need:

What is the PE and PB ratio of Cardio Diagnostics Holdings Inc?

The PE ratio of Cardio Diagnostics Holdings Inc is N/A and the PB ratio is 0.56.